Virtus LifeSci Profile

Performance

1515

Odds of Distress

Equity ratings for Virtus LifeSci Biotech Clinical are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting September 12, 2019 and ending today December 11, 2019. Click here to learn more.

Virtus LifeSci Profile

The etf is in a buyout trend. The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Virtus LifeSci is traded on BATS Exchange in USA. more
NameVirtus LifeSci Biotech Clinical
Macroaxis Advice
InstrumentUSA Etf View All
RegionNorth America
Investment IssuerVirtus
ExchangeBATS Exchange
Etf FamilyVirtus
Fund CategorySector
Portfolio ConcentrationHealth Care
BenchmarkDOW
Phone888 383 0553
CurrencyUSD - US Dollar
IssuerVirtus
DescriptionVirtus LifeSci Biotech Clinical Trials ETF
Inception Date2014-12-16
BenchmarkLifeSci Biotechnology Clinical Trials Index
Entity TypeRegulated Investment Company
Asset Under Management31.6 Million
Average Trading Valume12,875.3
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionNorth America
AdministratorVirtus ETF Solutions LLC
AdvisorVirtus ETF Advisers LLC
CustodianThe Bank of New York Mellon Corporation
DistributorETF Distributors LLC
Portfolio ManagerMatthew B. Brown, Seth Kadushin
Transfer AgentThe Bank of New York Mellon Corporation
Fiscal Year End31-Oct
ExchangeNYSE Arca, Inc.
Number of Constituents97.0
Market MakerVirtu Financial
Total Expense0.79
Management Fee0.79
Nav Price33.27
Two Hundred Day Average27.3
Ytd38.57%
Average Daily Volume In Three Month7.45k
Fifty Two Week Low20.22
As Of DateNovember 30, 2019
Average Daily Volume Last 10 Day29.68k
Fifty Two Week High36.08
One Month22.04%
Fifty Day Average28.73
Three Month21.47%
Virtus LifeSci Biotech Clinical [BBC] is traded in USA and was established 2014-12-16. The fund is classified under Health category within Virtus family. Virtus LifeSci Biotech currently have 28.95 M in assets under management (AUM). , while the total return for the last 3 years was 17.94%.
Check Virtus LifeSci Probability Of Bankruptcy

Geographic Allocation (%)

Sector Allocation (%)

Top Etf Constituents

Virtus LifeSci Target Price Odds Analysis

Odds Below 35.79HorizonTargetOdds Above 35.79
99.76%30 days 35.79 0.24%
Based on normal probability distribution, the odds of Virtus LifeSci to move above current price in 30 days from now is near 1 (This Virtus LifeSci Biotech Clinical probability density function shows the probability of Virtus LifeSci Etf to fall within a particular range of prices over 30 days) .

Virtus LifeSci Biotech Risk Profiles

Virtus LifeSci Biotech Technical Analysis

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. Virtus LifeSci Biotech Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe Virtus LifeSci price patterns. View also all equity analysis or get more info about inverse tangent over price movement math transform indicator.

Virtus LifeSci Key Fundamentals

Virtus LifeSci Against Markets

Did you try this?

Run Portfolio Comparator Now

   

Portfolio Comparator

Compare the composition, asset allocations and performance of any two portfolios in your account
All  Next Launch Module
Check also Trending Equities. Please also try Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Search macroaxis.com